MMSL 2025, 94(1):10-19 | DOI: 10.31482/mmsl.2023.045

SPECIFIC 23S rRNA GENE FOR DETECTION OF STENOTROPHOMONAS MALTOPHILIA ISOLATED FROM CLINICAL SOURCESOriginal article

Bassima M. Ali ORCID...*, Essra Gh Alsammak ORCID...
Department of Biology, College of Science, University of Mosul, Almajmoaa Street, 41002, Mosul, Iraq

Background: Stenotrophomonas infections are becoming more widespread around the world and can be counted as a “newly emerging pathogen of concern". The present study aimed to detect a variety of Stenotrophomonas species (S. maltophilia) using specific 23S rRNA gene primers and investigate their multi-drug resistance potential.

Methods: This study includes 375 clinical samples from different clinical sources 175 from males and 200 from females collected from Mosul City Hospital. Identification of Stenotrophomonas was conducted through multiple steps including culturing methods, molecular methods in addition to some biochemical tests 11(3%) of isolates belonged to Stenotrophomonas maltophilia. The isolates understudy were tested for their ability to resist 10 different antibiotics using the Kirby-Bauer disk diffusion method.

Results: The resistance rate to amoxicillin, gentamicin, and amikacin (100%), cefixime (91%), imipenem (64%), meropenem(55%), Azithromycin (36%), nalidixic acid and trimethoprim (18%), ciprofloxacin(0%). The virulence factors of S. maltophilia siderophores were found in all (11) isolates belonging to S. maltophilia at a percentage (100%). The result of PCR assay using specific primers designed for detecting 23S rRNA genes of S. maltophilia gives amplification for 11 isolates from 14 suspected isolates. Nucleic acid sequencing for the 23S rRNA gene shows that all isolates belong to S. maltophilia with a similarity rate (91-99) in NCBI.Because the 23S rRNA gene sequence in Stenotrophomonas species shows more variety in this location this study used specific 23S rRNA gene primers to identify S. maltophilia.

Conclusion: The study used phenotypic and molecular diagnostic techniques to isolate the bacteria, including the S rRNA23 gene. The results emphasize the need for increased vigilance in hospitals to prevent the spread of antibiotic-resistant bacteria and the development of new treatment strategies.

Keywords: Stenotrophomonas maltophilia; 23S rRNA gene; Siderophores; critically ill patients

Received: June 2, 2023; Revised: November 4, 2023; Accepted: December 15, 2023; Prepublished online: January 4, 2024; Published: March 3, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ali, B.M., & Alsammak, E.G. (2025). SPECIFIC 23S rRNA GENE FOR DETECTION OF STENOTROPHOMONAS MALTOPHILIA ISOLATED FROM CLINICAL SOURCES. MMSL94(1), 10-19. doi: 10.31482/mmsl.2023.045
Download citation

References

  1. Lim JK, Nguyen MH, Kim WR, et al. Prevalence of chronic hepatitis B virus infection in the United States. Official journal of the American College of Gastroenterology. ACG. 2020;115(9):1429-1438. https://doi.org/10.14309/ajg.0000000000000651. Go to original source... Go to PubMed...
  2. Jane A, Vyas M, Kumar A, et al. Liver fibrosis: pathophysiology, diagnosis, and emerging therapeutic targets for a common complication of chronic liver diseases. Georgian Med News. 2023 Jul-Aug:(340-341):93-100.
  3. Zhelezniakova NM, Tverezovska II. Diagnostic and prognostic value of selenium and Selenoprotein P in patients with a comorbid course of nonalcoholic fatty liver disease and arterial hypertension. Medicinski èasopis. 2022;56(2):68-76. https://doi.org/10.5937/mckg56-36421 Go to original source...
  4. Motsonelidze T, Kakhadze S, Gachechiladze D, et al. Significance of two-dimensional shear wave elastography in predicting oesophagal varicose veins during chronic liver disease. Georgian Medical News. 2023;1(337):77-84.
  5. Badra G, Lotfy M, El-Refaie A, et al. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients. Acta Microbiologica et Immunologica Hungarica. 2010;57(1):29-42. https://doi.org/10.1556/amicr.57.2010.1.3. Go to original source... Go to PubMed...
  6. Zhang X, Zhang D, Bu X, et al. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma. BMC bioinformatics. 2022;23(1):479. https://doi.org/10.1186/s12859-022-05040-y. Go to original source... Go to PubMed...
  7. Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harbor perspectives in medicine. 2015;5(5). https://doi.org/10.1101/cshperspect.a021436. Go to original source... Go to PubMed...
  8. Faulkes RE, Rehman Z, Palanichamy S, et al. Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis. Cancers. 2023;15(3):978. https://doi.org/10.3390/cancers15030978. Go to original source... Go to PubMed...
  9. Aziz Z, Sarhat E, Zaidan Z. Estimation of serum ferroportin and liver enzymes in breast cancer patients. Georgian medical news. 2023 Jun;(339):37-41.
  10. Drobinska N, Abrahamovych O, Abrahamovych M, et al. Characteristics of calcium-phosphorus metabolism and bone turnover indicators in patients with liver cirrhosis and their diagnostic value for assessing bone structures disorder. Georgian Medical News. 2023 Jan;(334):41-48.
  11. Alzubaidi ZM, Al-attar WM. Nurses knowledge about hepatitis c virus in Baghdad teaching hospitals: a cross-sectional study. Georgian Medical News. 2023;20(29):113.
  12. Sargsyan M. Specificities of the course of subclinical hepatitis among young adults with acute glomerulonephritis. Georgian Medical News. 2023;(334):52-56.
  13. Khalid I, Nayyef NS, Merkhan MM. A Taxonomic Study comparing the two types of Medicinal Leeches available in Iraq. Research Journal of Pharmacy and Technology. 2022;15(3):1119-1122. Go to original source...
  14. O'Brien A, Zhou T, Tan C, et al. Role of non-coding RNAs in the progression of liver cancer: Evidence from experimental models. Cancers. 2019;11(11):1652. https://doi.org/10.3390/cancers11111652. Go to original source... Go to PubMed...
  15. Liu J, Liu Y, Wang F, et al. miR-204: molecular regulation and role in cardiovascular and renal diseases. Hypertension. 2021;78(2):270-281. https://doi.org/10.1161/HYPERTENSIONAHA.121.14536. Go to original source... Go to PubMed...
  16. Liao Z, Zheng R, Shao G. Mechanisms and application strategies of miRNA 146a regulating inflammation and fibrosis at molecular and cellular levels. International Journal of Molecular Medicine. 2023;51(1):1-6. https://doi.org/10.3892/ijmm.2022.5210. Go to original source... Go to PubMed...
  17. Wang H, Li X, Li T, et al. Multiple roles of microRNA 146a in immune responses and hepatocellular carcinoma. Oncology Letters. 2019;18(5):5033-5042. https://doi.org/10.3892/ol.2019.10862. Go to original source... Go to PubMed...
  18. Larner-Svensson HM, Williams AE, Tsitsiou E, et al. Pharmacological studies of the mechanism and function of interleukin-1β-induced miRNA-146a expression in primary human airway smooth muscle. Respiratory research. 2010;11(1):1-3. https://doi.org/10.1186/1465-9921-11-68. Go to original source... Go to PubMed...
  19. Banerjee S, Thompson WE, Chowdhury I. Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. Frontiers in bioscience (Landmark edition). 2021;26(4):771. https://doi.org/10.2741/4917. Go to original source... Go to PubMed...
  20. Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harbor perspectives in medicine. 2014 Oct 30:a024935. https://doi.org/10.1101/cshperspect.a024935. Go to original source... Go to PubMed...
  21. Tarao K, Nozaki A, Ikeda T, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment. Cancer medicine. 2019;8(3):1054-1065. https://doi.org/10.1002/cam4.1998. Go to original source... Go to PubMed...
  22. Kroesen BJ, Teteloshvili N, Smigielska-Czepiel K, et al. Immuno-miRs: critical regulators of T-cell development, function and ageing. Immunology. 2015;144(1):1-10. https://doi.org/10.1111/imm.12367. Go to original source... Go to PubMed...
  23. Zhang Z, Zhang Y, Sun XX, et al. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Molecular cancer. 2015;14(1):1-5. https://doi.org/10.1186/1476-4598-14-5 Go to original source... Go to PubMed...
  24. Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. Wiley; 2018 Nov 13.
  25. Sadri Nahand J, Moghoofei M, Salmaninejad A, et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. International journal of cancer. 2020;146(2):305-320. https://doi.org/10.1002/ijc.32688. Go to original source... Go to PubMed...